Cognitive-Behavioral Therapy for Psychiatric Comorbidity in a Case of Muscle-Specific Kinase-Positive Myasthenia Gravis

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Myasthenia gravis (MG) is a chronic autoimmune disease characterized by neuromuscular transmission dysfunction. Depression and anxiety disorders are frequent in MG patients, and pharmacologic treatment may be compromised by adverse effects on neuromuscular transmission or respiratory depression. Cognitive-behavioral therapy (CBT) is an evidence-based form of psychotherapy for treatment of depression, anxiety disorders, and insomnia with the benefit of having no adverse effects on MG.